The Symptom Experience in Pediatric Cancer: Current Conceptualizations and Future Directions

Lindsay A Jibb1,2, Suzanne Ameringer3, Catherine Fiona Macpherson4

  • 1Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, M5T 1P8, Toronto, Canada. lindsay.jibb@sickkids.ca.

Current Oncology Reports
|February 12, 2022
PubMed

Insights

Understanding childhood cancer symptoms requires considering biology, family, and environment. Research gaps exist in symptom assessment and management partnerships, necessitating personalized care strategies.

Area of Science:

  • Pediatric Oncology
  • Symptom Management
  • Quality of Life Research

Background:

  • Childhood cancer symptoms are prevalent and distressing, significantly impacting quality of life for both children and their families.
  • Numerous interacting factors, including socioeconomic status, biology, genetics, psychosocial dynamics, and environmental influences, shape the childhood cancer symptom experience.
  • Current research has identified gaps in routine symptom assessment and the establishment of effective family-centered symptom management strategies.

Purpose of the Study:

  • To review recent research on the childhood cancer symptom experience.
  • To identify factors influencing symptom experience, including socioeconomic, biological, genetic, psychosocial, and environmental aspects.
  • To formulate recommendations for a personalized approach to symptom management in pediatric oncology.

Main Methods:

  • Literature review of recent research on childhood cancer symptom experience.
  • Analysis of factors influencing symptom presentation and impact.
  • Synthesis of findings to identify research gaps and clinical implications.

Main Results:

  • Childhood cancer symptom experience is multifactorial, influenced by biological, genetic, developmental, family, and environmental factors.
  • Significant gaps exist in routine symptom assessment and the integration of family psychosocial dynamics into care.
  • Socioeconomic factors play a crucial role in symptom experience and access to care.

Conclusions:

  • Personalized symptom management strategies are essential for improving outcomes in pediatric oncology.
  • Future research should focus on addressing identified gaps in assessment and family-centered care.
  • Translating research findings into clinical practice is critical for enhancing the quality of life for children with cancer.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
473
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K